Intensive Nutrition in ARDS: A Clinical Trial (INTACT)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT01071330
First received: February 17, 2010
Last updated: April 16, 2010
Last verified: November 2009
  Purpose

We propose a prospective randomized clinical trail to evaluate the impact of intensive medical nutrition therapy (IMNT) in malnourished patients with ARDS on short and long-term outcomes. Participant's (N = 200) will be randomized to receive either standard care (SC e.g. ad lib feeding of standard food) or IMNT provided early as EN and continued as intensive diet therapy tailored to maximize oral intake until hospital discharge. Primary outcomes evaluated include infections while hospitalized, immune parameters (CD4 and CD8 cells, serum IL-10 and leptin levels,l numbers of T regulatory cells and markers for T cell anergy), days on mechanical ventilation, in the ICU and hospital , and changes in fat free mass(measured by dual energy x-ray absorptiometry), weight, muscular weakness (measured as hand grip strength), fatigue (measured as distanced traveled in 6-minute walk) and pulmonary function.


Condition Intervention Phase
Acute Respiratory Distress Syndrome
Other: intensive medical nutrition therapy
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Phase 2 Study of Medical Nutritional Therapy vs. Standard Care in Patients With Acute Respiratory Distress Syndrome

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • incidence of infection [ Time Frame: hospitalizatioin ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • require fewer days of mechanical ventilation [ Time Frame: hospitalization ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: July 2009
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: intensive medical nutrition therapy
intensive medical nutrition therapy is early enteral nutrition + intensive diet therapy when oral intake is initiated to meet the patients energy and protein needs from hospital admission to discharge. Standard care is that nutritional care provided by routine medical care.
Other: intensive medical nutrition therapy
Intensive medical nutritional therapy provides patients with early enteral nutrition + intensive diet therapy when oral intake is initiated to meet energy and protein needs from hospital admission to discharge

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: adult patients with acute lung injury or acute respiratory distress syndrome

-

Exclusion Criteria:

  • HIV, DNR, active cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01071330

Locations
United States, Illinois
RUSH University Medical Center
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
Investigators
Principal Investigator: Carol Braunschweig, PhD University of Illinois
  More Information

No publications provided

Responsible Party: Carol Braunschweig Associate Professor, University of Illinois at Chicago
ClinicalTrials.gov Identifier: NCT01071330     History of Changes
Other Study ID Numbers: 685, 5R01HL093142-02
Study First Received: February 17, 2010
Last Updated: April 16, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Acute Lung Injury
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases
Lung Injury

ClinicalTrials.gov processed this record on May 16, 2013